Application of low-intensity pulsed ultrasound in combination with microbubbles might enhance the delivery of chemotherapy medication used for treating cancers. In their study, a team of Lithuanian researchers from three universities – KTU, LSMU and VMU – claim that the rate of microbubble survival time is the best indicator for determining the efficiency of sonoporation, i.e. ultrasound-induced laceration of the cancer cell membrane.
Krūties vėžys
Krūties vėžys
© Shutterstock

Poor drug delivery into cancer cells is one of the greatest concerns in anticancer therapy. Insufficient drug concentration in the tumour limits medication’s therapeutic efficacy, therefore the researchers all over the world are looking for solutions that would enhance its transport into cancer cells. One of the methods that are getting increased attention recently is sonoporation caused by ultrasound.

There are two main mechanisms by which ultrasound may affect drug transport into cells. Firstly, under the effect of ultrasound, all fluid starts moving in oscillatory fashion and this may enhance the diffusion of the molecules through the cell membrane. Another mechanism includes usage of microbubbles to damage the structure of cells. The tiny (1–4 μm in diameter) gas-filled spheres coated with a shell made of lipids, polymers, and proteins are used to enhance the ultrasound imaging procedure. It has been observed that ultrasound causes microbubbles to rapidly expand and contract – this phenomenon is called cavitation. Cavitation causes the flow of the fluid around the microbubble, and the produced shear forces may create small pores in cell membranes.

“The method where ultrasound together with microbubbles is used to improve the anticancer medication delivery into cancer cells is widely researched. Although mainly research is conducted in a laboratory environment during in vitro studies, first clinical trials have already started. We believe that our research results will add to the development of global knowledge in this critical topic”, says professor Dr Renaldas Raišutis, Head of Numerical Simulation Laboratory of Ultrasound Research Institute at Kaunas University of Technology (KTU).

Renaldas Raišutis
Renaldas Raišutis
© KTU archyvas

While researching the sonoporation for improving the efficiency of the anticancer medication, the multi-disciplinary team of researchers from three Lithuanian universities worked together – Lithuanian University of Health Sciences (LSMU), Vytautas Magnus University (VMU) and KTU. After numerous studies, in which the researchers analysed ultrasound penetration signals under different acoustic pressure and duration of exposure, they have improved the method of predicting the efficiency of sonoporation. The research conducted by Lithuanian scientists reveals that microbubble survival time is the universal estimate, which defines the optimal duration of exposure for sonoporation.

“Our main finding is that only time-dependent estimate, the rate of microbubble survival time is needed to predict the efficiency of sonoporation. Therefore, our metrics are more advanced than the currently used inertia cavitation control variable”, explains Prof Raišutis.

Moreover, while studying the anticancer medication doxorubicin delivery into spherical (3D) cancer cell culture (a model for conducting experiments, which is more closely able to mimic conditions in vivo), KTU researchers together with the team from LSMU have determined the ultimate combination of microbubbles and ultrasound, that would enhance the transport of the drug into the tumour tissue.
During the research, which took place over several years, the scientists from KTU, LSMU and VMU were solving numerous problems related to the development of the ultrasound technology needed for delivering anticancer medication, the determination of ultrasound parameters for exposure and analysing the ultrasound penetration signals. According to Prof Raišutis, all the partners have actively participated and contributed to the research according to their fields of expertise.

It is forbidden to copy the text of this publication without a written permission from DELFI.

Lithuania asks ECHR to join case on Russian aggression in Ukraine

Lithuania on Friday asked the European Court of Human Rights (ECHR) to join its case on Russia's...

MP Gedvilas will seek to become Labour Party’s leader

MP Aidas Gedvilas has decided to take part in the upcoming election of a new leader of the Labour Party.

Lithuania launches probe into pro-Russian Ukrainian blogger's finances

Lithuania's Prosecutor General's Office last week launched an investigation into the assets and...

1 318 new COVID-19 cases, no deaths

Lithuania has recorded 1,318 new coronavirus infections and no deaths from COVID-19 over the past 24...

30 migrants tried to access Lithuania illegally from Belarus

On Thursday, 11 August, Lithuanian border guards stopped 30 illegal migrants at the border as they...

Top news

Deficit on current account balance increased significantly in June

The Bank of Lithuania has published the balance of payments for June 2022, which shows that the...

Industrial production down by 1.8% in June

In June 2022, the seasonally adjusted industrial production rose by 0.7% in the euro area and by 0.6%...

Innovation developed by Lithuanian scientists will allow more efficient screening of voice pathologies

In cases of advanced laryngeal cancer, a complex surgery called laryngectomy is performed, when the...

Lithuania asks ECHR to join case on Russian aggression in Ukraine

Lithuania on Friday asked the European Court of Human Rights (ECHR) to join its case on Russia's...

Bajarunas proposed for ambassador to United Kingdom

Eitvydas Bajarunas has been proposed for Lithuanian ambassador to the United Kingdom, under a draft...